Spectral AI, Inc. announced the appointment of Prof. Paul Chadwick as Executive Vice President of the Company?s United Kingdom subsidiary. Prof. Chadwick is an experienced clinical scientist and wound care key opinion leader with an impressive body of work including a substantial and impactful publication record, particularly in the domain of diabetic wound management. He will be responsible for the international market expansion of the Company?s DeepView® wound imaging technology in the United Kingdom, Europe, Middle East and Africa (EMEA), all of which are geographic areas where Prof. Chadwick has extensive clinical networks, significant experience and has enjoyed previous successes.

Prof. Chadwick?s impressive journey stretches across clinical, academic and business disciplines. In his previous roles at the Royal College of Podiatry, Prof. Chadwick led all the clinical, educational and financial aspects of the organization. In addition, he has held multiple leadership positions such as consultant podiatrist at The National Health Service (NHS), and Managing Director at Curativo Wound Care Consultancy, where he has served companies such as 3M, Molnlycke Health Care, Smith & Nephew, Advancis, Thornton & Ross, Essity and many others.

In his capacity as a prominent authority in wound care, Prof. Chadwick fulfills critical roles on advisory boards and exemplifies best practices in the field. Furthermore, he generously imparts his knowledge as an adjunct professor at Birmingham City University, where he teaches in the Health and Life Sciences Department. Prof. Chadwick earned his Ph.D. with a thesis on aspects of painful diabetic neuropathy at the University of Salford.

He earned his M.Sc. with a focus on foot ulceration from Manchester Metropolitan University and holds an undergraduate degree in Science Honors from the University of Brighton.